ClinicalThought

Share

Program Content

Activities

  • FAQs: BTKi in MCL
    FAQs: BTK Inhibitors in MCL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 24, 2024

Faculty

cover img faculity

Ann LaCasce, MD, MMSc

Associate Professor of Medicine
Lymphoma Program
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

John P. Leonard, MD

Senior Associate Dean for Innovation and Initiatives
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York

cover img faculity

Matthew Lunning, DO, FACP

Associate Professor
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca